Search Results

Filter
  • 1-10 of  269 results for ""Cholinesterase Inhibitors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.

  • Authors : Schmidt R; Department of Neurology, Medical University of Graz, Graz, Austria.; Hofer E

Subjects: Drug Therapy, Combination* ; Practice Guidelines as Topic*; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy

  • Source: European journal of neurology [Eur J Neurol] 2015 Jun; Vol. 22 (6), pp. 889-98. Date of Electronic Publication: 2015 Mar 25.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331

Record details

×
Academic Journal

Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.

  • Authors : Schultz K; Department of Experimental Medical Science, Translational Neuroendocrine Research Unit, Lund University, Lund, Sweden. ; Nilsson K

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*cerebrospinal fluid ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*therapeutic use

  • Source: European journal of neurology [Eur J Neurol] 2010 Mar; Vol. 17 (3), pp. 456-60. Date of Electronic Publication: 2009 Nov 17.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331

Record details

×
Academic Journal

Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.

  • Authors : Schreglmann SR; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.; Department of Neurology, Kantonsspital St Gallen, St Gallen, Switzerland.

Subjects: Blood Pressure/Blood Pressure/Blood Pressure/*drug effects ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*therapeutic use ; Fludrocortisone/Fludrocortisone/Fludrocortisone/*therapeutic use

  • Source: European journal of neurology [Eur J Neurol] 2017 Apr; Vol. 24 (4), pp. 545-551. Date of Electronic Publication: 2017 Feb 22.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331

Record details

×
Academic Journal

How long can patients with mild or moderate Alzheimer's dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study.

  • Authors : Sun Y; Department of Neurology, En Chu Kong Hospital, Taipei, Taiwan. ; Lai MS

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*physiopathology ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*therapeutic use

  • Source: European journal of neurology [Eur J Neurol] 2008 Mar; Vol. 15 (3), pp. 278-83.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic)

Record details

×
Report

Is there still a role for edrophonium in diagnosing ocular myasthenia.

Subjects: Cholinesterase Inhibitors* ; Edrophonium*; Myasthenia Gravis/Myasthenia Gravis/Myasthenia Gravis/*diagnosis

  • Source: European journal of neurology [Eur J Neurol] 2007 Mar; Vol. 14 (3), pp. e4-5.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic)

Record details

×
Academic Journal

Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease.

  • Authors : Kurz AF; Department of Psychiatry and Psychotherapy, Technische Universitaet Munchen, Munich, Germany. ; Erkinjuntti T

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Cerebrovascular Disorders/Cerebrovascular Disorders/Cerebrovascular Disorders/*drug therapy ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*therapeutic use

  • Source: European journal of neurology [Eur J Neurol] 2003 Nov; Vol. 10 (6), pp. 633-40.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Print ISSN: 1351-5101 (Print) Linking

Record details

×
Academic Journal

A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon).

  • Authors : Forette F; Centre de Gerontologie, Hopital Broca, 54-56 rue Pascal, 75013, Paris, France. ; Anand R

Subjects: Phenylcarbamates*; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Carbamates/Carbamates/Carbamates/*therapeutic use

  • Source: European journal of neurology [Eur J Neurol] 1999 Jul; Vol. 6 (4), pp. 423-9.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Print ISSN: 1351-5101 (Print) Linking

Record details

×
Academic Journal

The apolipoprotein E epsilon4 allele and the response to tacrine therapy in Alzheimer's disease.

  • Authors : Rigaud AS; Hôpital Broca, 54-56 Rue Pascal, 75013, Paris, France. ; Traykov L

Subjects: Alleles*; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*genetics

  • Source: European journal of neurology [Eur J Neurol] 2000 May; Vol. 7 (3), pp. 255-8.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Print ISSN: 1351-5101 (Print) Linking

Record details

×
Academic Journal

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.

  • Authors : Pirttilä T; Department of Neuroscience and Neurology, University of Kuopio, Kuopio, Finland. ; Wilcock G

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*adverse effects ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*therapeutic use

  • Source: European journal of neurology [Eur J Neurol] 2004 Nov; Vol. 11 (11), pp. 734-41.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Print ISSN: 1351-5101 (Print) Linking

Record details

×
  • 1-10 of  269 results for ""Cholinesterase Inhibitors""